2026-01-05
By celnovte
A new article titled “FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneity” has been published in Virchows Archiv (Springer Nature, 2025).
This study provides an in-depth clinicopathologic and molecular analysis of rare FLCN-mutated renal tumors, emphasizing their diverse morphologies and diagnostic complexity.
Importantly, the research utilized the SDHB antibody from Celnovte for immunohistochemical validation—demonstrating high reliability and staining consistency in detecting metabolic-related renal tumors.
These findings advance our understanding of renal tumor classification and underscore the critical role of high-quality antibodies in precision pathology.
🔗 Read the full article: DOI: 10.1007/s00428-025-04289-x